{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:06:29Z","timestamp":1793307989519,"version":"4.5.0"},"reference-count":339,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH024"],"award-info":[{"award-number":["ZR2022MH024"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2018ZC1054"],"award-info":[{"award-number":["ZR2018ZC1054"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cellsig.2026.112452","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:10:50Z","timestamp":1772093450000},"page":"112452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Exosome-mediated crosstalk between immune cells and tumor microenvironment in lung cancer: Implications for immune evasion and therapeutic resistance"],"prefix":"10.1016","volume":"142","author":[{"given":"Ruitong","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqian","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangtao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"13","key":"10.1016\/j.cellsig.2026.112452_bb0010","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/CM9.0000000000002529","article-title":"Global burden and trends of lung cancer incidence and mortality","volume":"136","author":"Li","year":"2023","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112452_bb0020","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170070","article-title":"Progress and prospects of early detection in lung cancer","volume":"7","author":"Blandin Knight","year":"2017","journal-title":"Open Biol."},{"key":"10.1016\/j.cellsig.2026.112452_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108586","article-title":"Targeting CAFs and extracellular matrix (ECM) in lung cancer: potential of adjuvants and nanoparticles","volume":"162","author":"Feng","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13046-019-1110-6","article-title":"Collagens and cancer associated fibroblasts in the reactive stroma and its relation to cancer biology","volume":"38","author":"Nissen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112452_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121600","article-title":"Exosome biogenesis in the protozoa parasite giardia lamblia: a model of reduced interorganellar crosstalk","volume":"8","author":"Moyano","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12015-017-9776-7","article-title":"Evidence of extracellular vesicles biogenesis and release in mouse embryonic stem cells","volume":"14","author":"Cruz","year":"2018","journal-title":"Stem Cell Rev. Rep."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112452_bb0050","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/s41423-025-01323-5","article-title":"The role of exosomes in immunopathology and potential therapeutic implications","volume":"22","author":"Wang","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188340","article-title":"Communication in tiny packages: exosomes as means of tumor-stroma communication","volume":"1873","author":"Da\u00dfler-Plenker","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.cellsig.2026.112452_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2020.03.017","article-title":"Hypoxia in tumor microenvironment regulates exosome biogenesis: molecular mechanisms and translational opportunities","volume":"479","author":"Kumar","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-022-01305-4","article-title":"Emerging role of exosomes in cancer progression and tumor microenvironment remodeling","volume":"15","author":"Paskeh","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112452_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1025218","article-title":"Exosomes in the tumor microenvironment: promoting cancer progression","volume":"13","author":"Jin","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb0075","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.trecan.2020.03.002","article-title":"Exosomal PD-L1: roles in tumor progression and immunotherapy","volume":"6","author":"Morrissey","year":"2020","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188624","article-title":"New insights into exosome mediated tumor-immune escape: clinical perspectives and therapeutic strategies","volume":"1876","author":"Pathania","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0085","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1172\/JCI81136","article-title":"Exosomes and tumor-mediated immune suppression","volume":"126","author":"Whiteside","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2026.112452_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6272498","article-title":"Tumor-derived exosomes in immunosuppression and immunotherapy","volume":"2020","author":"Olejarz","year":"2020","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0095","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12967-025-06814-7","article-title":"Tumor-derived exosomes and their application in cancer treatment","volume":"23","author":"Javdani-Mallak","year":"2025","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112452_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104061","article-title":"Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance","volume":"29","author":"Panda","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cellsig.2026.112452_bb0105","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","article-title":"Exosomes","volume":"88","author":"Pegtel","year":"2019","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0110","article-title":"Current knowledge on exosome biogenesis, cargo-sorting mechanism and therapeutic implications","volume":"12","author":"Xie","year":"2022","journal-title":"Membranes (Basel)"},{"issue":"6478","key":"10.1016\/j.cellsig.2026.112452_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112452_bb0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41556-021-00693-y","article-title":"Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker","volume":"23","author":"Kugeratski","year":"2021","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-020-01199-1","article-title":"Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology","volume":"19","author":"Hu","year":"2020","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s13402-023-00810-z","article-title":"Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer","volume":"46","author":"Patel","year":"2023","journal-title":"Cell. Oncol. (Dordr)"},{"key":"10.1016\/j.cellsig.2026.112452_bb0135","article-title":"Review on strategies and technologies for exosome isolation and purification","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112452_bb0140","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3390\/biom13111574","article-title":"The role of exosome-derived microRNA on lung cancer metastasis progression","volume":"13","author":"Martinez-Espinosa","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0145","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1186\/s12935-020-01653-6","article-title":"Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13046-023-02753-7","article-title":"Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts","volume":"42","author":"Khan","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12967-021-02985-1","article-title":"The role of exosomes in lung cancer metastasis and clinical applications: an updated review","volume":"19","author":"Yin","year":"2021","journal-title":"J. Transl. Med."},{"issue":"51","key":"10.1016\/j.cellsig.2026.112452_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038492","article-title":"Exosomal long non-coding RNAs in lung cancer: a review","volume":"103","author":"Jiang","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/febs.15558","article-title":"Exosomes as mediators of immune regulation and immunotherapy in cancer","volume":"288","author":"Kugeratski","year":"2021","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13073-018-0535-4","article-title":"The emerging roles of exosomes in the modulation of immune responses in cancer","volume":"10","author":"Kurywchak","year":"2018","journal-title":"Genome Med."},{"key":"10.1016\/j.cellsig.2026.112452_bb0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/9780470035399.ch16","article-title":"Innate and adaptive immunity in lung cancer","volume":"279","author":"Vella","year":"2006","journal-title":"Novartis Found. Symp."},{"issue":"19","key":"10.1016\/j.cellsig.2026.112452_bb0180","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-16-0431","article-title":"The emerging role of B cells in tumor immunity","volume":"76","author":"Tsou","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112452_bb0185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3389\/fimmu.2018.00819","article-title":"The potential biomarkers and immunological effects of tumor-derived exosomes in lung cancer","volume":"9","author":"Alipoor","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112452_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1073947","article-title":"Tumor-related exosomes contribute to tumor-promoting microenvironment: an immunological perspective","volume":"2017","author":"Chen","year":"2017","journal-title":"J Immunol Res"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112452_bb0195","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri.2016.80","article-title":"Regulatory circuits of T cell function in cancer","volume":"16","author":"Speiser","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"55","key":"10.1016\/j.cellsig.2026.112452_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd5778","article-title":"Contribution of resident and circulating precursors to tumor-infiltrating CD8(+) T cell populations in lung cancer","volume":"6","author":"Gueguen","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cellsig.2026.112452_bb0205","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3389\/fimmu.2020.02105","article-title":"Tumor-infiltrating lymphocytes and their prognostic value in cutaneous melanoma","volume":"11","author":"Maibach","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0210","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41419-020-2230-9","article-title":"circRNA-002178 act as a ceRNA to promote PDL1\/PD1 expression in lung adenocarcinoma","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb0220","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.apsb.2021.09.010","article-title":"The generation of PD-L1 and PD-L2 in cancer cells: from nuclear chromatin reorganization to extracellular presentation","volume":"12","author":"Fan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0225","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-021-01448-x","article-title":"Cancer cell-derived exosomal circUSP7 induces CD8(+) T cell dysfunction and anti-PD1 resistance by regulating the miR-934\/SHP2 axis in NSCLC","volume":"20","author":"Chen","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112452_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121765","article-title":"Novel antitumor therapeutic strategy using CD4(+) T cell-derived extracellular vesicles","volume":"289","author":"Shin","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.cellsig.2026.112452_bb0235","doi-asserted-by":"crossref","first-page":"20254","DOI":"10.1038\/srep20254","article-title":"Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets","volume":"6","author":"Muller","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112452_bb0240","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s00262-022-03196-3","article-title":"Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1(+) fibroblast and CCR8(+) Treg cell interactions","volume":"71","author":"Wang","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"32","key":"10.1016\/j.cellsig.2026.112452_bb0245","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2201899119","article-title":"Tumor-polarized GPX3(+) AT2 lung epithelial cells promote premetastatic niche formation","volume":"119","author":"Wang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2026.112452_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101564","article-title":"Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells","volume":"27","author":"Wu","year":"2023","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112452_bb0260","article-title":"On-chip biogenesis of circulating NK cell-derived exosomes in non-small cell lung cancer exhibits antitumoral activity","volume":"8","author":"Kang","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0265","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13258-022-01306-0","article-title":"MiR-30c facilitates natural killer cell cytotoxicity to lung cancer through targeting GALNT7","volume":"45","author":"Gao","year":"2023","journal-title":"Genes Genom."},{"key":"10.1016\/j.cellsig.2026.112452_bb0270","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mehy.2017.09.003","article-title":"Could lung cancer exosomes induce apoptosis of natural killer cells through the p75NTR-proNGF-sortilin axis?","volume":"108","author":"Zhu","year":"2017","journal-title":"Med. Hypotheses"},{"issue":"Pt 18","key":"10.1016\/j.cellsig.2026.112452_bb0275","first-page":"3983","article-title":"Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors","volume":"127","author":"Wilson","year":"2014","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb0280","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.21037\/tcr-21-536","article-title":"Impact of high-dose rate radiotherapy on B and natural killer (NK) cell polarization in peripheral blood mononuclear cells (PBMCs) via inducing non-small cell lung cancer (NSCLC)-derived exosomes","volume":"10","author":"Lei","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051303","article-title":"Lung tumor cell-derived exosomes promote M2 macrophage polarization","volume":"9","author":"Pritchard","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0290","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ymthe.2017.11.016","article-title":"Hypoxic lung-cancer-derived extracellular vesicle MicroRNA-103a increases the oncogenic effects of macrophages by targeting PTEN","volume":"26","author":"Hsu","year":"2018","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-022-00598-y","article-title":"LINC00963 promotes the malignancy and metastasis of lung adenocarcinoma by stabilizing Zeb1 and exosomes-induced M2 macrophage polarization","volume":"29","author":"Hu","year":"2023","journal-title":"Mol. Med."},{"issue":"31","key":"10.1016\/j.cellsig.2026.112452_bb0300","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb0305","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.21037\/tlcr-20-1255","article-title":"Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer","volume":"10","author":"Li","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0310","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3892\/ol.2022.13476","article-title":"Tumor-associated macrophage-derived exosomes promote EGFR-TKI resistance in non-small cell lung cancer by regulating the AKT, ERK1\/2 and STAT3 signaling pathways","volume":"24","author":"Yuan","year":"2022","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0315","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00011-020-01318-0","article-title":"Tumor-derived exosomes in the regulation of macrophage polarization","volume":"69","author":"Baig","year":"2020","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2026.112452_bb0325","doi-asserted-by":"crossref","first-page":"10693","DOI":"10.2147\/OTT.S256669","article-title":"Lung carcinoma cells secrete exosomal MALAT1 to inhibit dendritic cell phagocytosis, inflammatory response, costimulatory molecule expression and promote dendritic cell autophagy via AKT\/mTOR pathway","volume":"13","author":"Liu","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"13","key":"10.1016\/j.cellsig.2026.112452_bb0330","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/s41388-020-1182-y","article-title":"EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells","volume":"39","author":"Yu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2026.112452_bb0335","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2018.05.002","article-title":"Tumor exosomes block dendritic cells maturation to decrease the T cell immune response","volume":"199","author":"Ning","year":"2018","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0340","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7150\/ijbs.38414","article-title":"Tumor cell-associated exosomes robustly elicit anti-tumor immune responses through modulating dendritic cell vaccines in lung tumor","volume":"16","author":"Wang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellsig.2026.112452_bb0345","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2022.11.053","article-title":"Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies","volume":"353","author":"Li","year":"2023","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0350","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and significance of the pre-metastatic Niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112452_bb0355","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41419-021-04024-9","article-title":"Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2","volume":"12","author":"Kim","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0360","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000488119","article-title":"Anti-angiogenics: their value in lung cancer therapy","volume":"41","author":"Janning","year":"2018","journal-title":"Oncol. Res. Treat."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0365","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1038\/s41467-018-07810-w","article-title":"Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis","volume":"9","author":"Zeng","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0370","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","article-title":"Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells","volume":"20","author":"Yan","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112452_bb0375","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41419-022-05420-5","article-title":"Cancer-derived exosomal miR-197-3p confers angiogenesis via targeting TIMP2\/3 in lung adenocarcinoma metastasis","volume":"13","author":"Chang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112452_bb0380","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41419-021-04037-4","article-title":"Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP\/KLF2 in non-small cell lung cancer","volume":"12","author":"Ma","year":"2021","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112452_bb0385","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41419-023-06007-4","article-title":"Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1","volume":"14","author":"Luo","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0390","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2023.2190065","article-title":"Exosomal miR-133a-3p promotes the growth and metastasis of lung cancer cells following incomplete microwave ablation","volume":"40","author":"Yang","year":"2023","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.cellsig.2026.112452_bb0395","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.2147\/CMAR.S263768","article-title":"Hypoxic non-small-cell lung cancer cell-secreted exosomal microRNA-582-3p drives cancer cell malignant phenotypes by targeting secreted frizzled-related Protein 1","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.cellsig.2026.112452_bb0400","article-title":"Exosomal lncRNA SCIRT\/miR-665 transferring promotes lung cancer cell metastasis through the inhibition of HEYL","volume":"2021","author":"Wang","year":"2021","journal-title":"J. Oncol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0405","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/cbin.11531","article-title":"Stromal-derived miR-486-5p promotes metastasis of non-small-cell lung cancer cells by targeting the CADM1\/tight junctions axis in vascular endothelial cells","volume":"45","author":"Sun","year":"2021","journal-title":"Cell Biol. Int."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb0410","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.21037\/tlcr-21-356","article-title":"Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1","volume":"10","author":"Mao","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112452_bb0415","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1002\/jcp.29578","article-title":"Exosome-mediated transfer of miR-1260b promotes cell invasion through Wnt\/\u03b2-catenin signaling pathway in lung adenocarcinoma","volume":"235","author":"Xia","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb0420","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.325","article-title":"The EGFR\/miR-338-3p\/EYA2 axis controls breast tumor growth and lung metastasis","volume":"8","author":"Liang","year":"2017","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-022-00441-w","article-title":"MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K\/AKT signaling","volume":"11","author":"Zhu","year":"2023","journal-title":"Biomark. Res."},{"issue":"Pt 1","key":"10.1016\/j.cellsig.2026.112452_bb0430","article-title":"Exosomal miR-130b-3p suppresses metastasis of non-small cell lung cancer cells by targeting DEPDC1 via TGF-\u03b2 signaling pathway","volume":"275","author":"Lv","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb0435","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/1759-7714.13759","article-title":"Exosomal miR-3180-3p inhibits proliferation and metastasis of non-small cell lung cancer by downregulating FOXP4","volume":"12","author":"Chen","year":"2021","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.cellsig.2026.112452_bb0440","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fphys.2018.00557","article-title":"The role of apelin in cardiovascular diseases, obesity and cancer","volume":"9","author":"Wysocka","year":"2018","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0445","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/carcin\/bgaa089","article-title":"Apelin enhances biological functions in lung cancer A549 cells by downregulating exosomal miR-15a-5p","volume":"42","author":"Ran","year":"2021","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112452_bb0450","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41419-021-04314-2","article-title":"Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway","volume":"12","author":"Tian","year":"2021","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112452_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813925","article-title":"Long noncoding RNA ZBED5-AS1 facilitates tumor progression and metastasis in lung adenocarcinoma via ZNF146\/ATR\/Chk1 axis","volume":"24","author":"Jiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112452_bb0460","doi-asserted-by":"crossref","DOI":"10.1177\/1533033821990090","article-title":"Long noncoding RNA FGD5-AS1 knockdown decrease viability, migration, and invasion of non-small cell lung cancer (NSCLC) cells by regulating the MicroRNA-944\/MACC1 axis","volume":"20","author":"Lv","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"issue":"27","key":"10.1016\/j.cellsig.2026.112452_bb0465","doi-asserted-by":"crossref","first-page":"17217","DOI":"10.1021\/acsomega.1c00905","article-title":"Role and mechanism of exosome-derived long noncoding RNA HOTAIR in lung cancer","volume":"6","author":"Chen","year":"2021","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0470","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12943-020-01221-6","article-title":"Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0475","doi-asserted-by":"crossref","first-page":"8937","DOI":"10.1080\/21655979.2022.2056822","article-title":"Cancer-released exosomal circular RNA circ_0008717 promotes cell tumorigenicity through microRNA-1287-5p\/P21-activated kinase 2 (PAK2) axis in non-small cell lung cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Bioengineered"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0480","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.7150\/ijbs.66770","article-title":"CircRAPGEF5 promotes the proliferation and metastasis of lung adenocarcinoma through the miR-1236-3p\/ZEB1 axis and serves as a potential biomarker","volume":"18","author":"Zhou","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114097","article-title":"Exosomal LRG1 promotes non-small cell lung cancer proliferation and metastasis by binding FN1 protein","volume":"439","author":"Wu","year":"2024","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cellsig.2026.112452_bb0490","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cytogfr.2019.12.010","article-title":"Tumor-derived extracellular vesicles and microRNAs: functional roles, diagnostic, prognostic and therapeutic options","volume":"51","author":"Pontecorvi","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188776","article-title":"Role of exosomes in lung cancer: a comprehensive insight from immunomodulation to theragnostic applications","volume":"1877","author":"Khan","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"6024","key":"10.1016\/j.cellsig.2026.112452_bb0500","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112452_bb0505","first-page":"1","article-title":"Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0510","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0515","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.ymthe.2020.12.034","article-title":"Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels","volume":"29","author":"Zhou","year":"2021","journal-title":"Mol. Ther."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112452_bb0520","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1158\/0008-5472.CAN-16-0868","article-title":"The biodistribution and immune suppressive effects of breast cancer-derived exosomes","volume":"76","author":"Wen","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0525","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12964-022-00904-5","article-title":"Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling","volume":"20","author":"Gao","year":"2022","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0530","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1756-9966-28-150","article-title":"The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells","volume":"28","author":"Wan","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112452_bb0535","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.6061\/clinics\/2012(12)05","article-title":"Differential expression of hypoxia-inducible factor 1\u03b1 in non-small cell lung cancer and small cell lung cancer","volume":"67","author":"Karetsi","year":"2012","journal-title":"Clinics"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112452_bb0540","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.3390\/cells10102617","article-title":"Exosomes in the tumor microenvironment: from biology to clinical applications","volume":"10","author":"da Costa","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0545","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nm.4467","article-title":"Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0550","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-019-0772-z","article-title":"Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment","volume":"12","author":"Tian","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"41","key":"10.1016\/j.cellsig.2026.112452_bb0555","doi-asserted-by":"crossref","first-page":"43992","DOI":"10.18632\/oncotarget.6083","article-title":"The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2026.112452_bb0560","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2147\/OTT.S291611","article-title":"Serum exosomal miRNA might be a novel liquid biopsy to identify leptomeningeal metastasis in non-small cell lung cancer","volume":"14","author":"Xu","year":"2021","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0565","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12935-021-02197-z","article-title":"MicroRNA-550a-3-5p controls the brain metastasis of lung cancer by directly targeting YAP1","volume":"21","author":"Wei","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cellsig.2026.112452_bb0570","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.825899","article-title":"Exosomal lncRNA LINC01356 derived from brain metastatic nonsmall-cell lung cancer cells remodels the blood-brain barrier","volume":"12","author":"Geng","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0575","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1096\/fj.201800428R","article-title":"Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain","volume":"33","author":"Xu","year":"2019","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0580","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12951-024-02414-7","article-title":"Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases","volume":"22","author":"Jiang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0585","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13046-019-1092-4","article-title":"LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K\/AKT\/MYC pathway","volume":"38","author":"Wei","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0590","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13578-023-01112-5","article-title":"Comparative proteomic profiling of plasma exosomes in lung cancer cases of liver and brain metastasis","volume":"13","author":"Li","year":"2023","journal-title":"Cell Biosci."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112452_bb0595","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1038\/s41388-022-02322-w","article-title":"Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis","volume":"41","author":"Tyagi","year":"2022","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112452_bb0600","first-page":"473","article-title":"Exosomes from PM (2.5)-treated human bronchial epithelial cells increase lung cancer metastatic potential","volume":"35","author":"Yu","year":"2022","journal-title":"Biomed. Environ. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb0605","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41419-021-03928-w","article-title":"Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p\/RAC1 signalling axis in osteoclasts","volume":"12","author":"Ni","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112452_bb0610","article-title":"The potential roles of exosomal miR-214 in bone metastasis of lung adenocarcinoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0615","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt356","article-title":"Wnt signaling pathway in non-small cell lung cancer","volume":"106","author":"Stewart","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0620","article-title":"Wnt signaling pathway in development and cancer","volume":"69","author":"Taciak","year":"2018","journal-title":"J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0625","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10585-020-10062-y","article-title":"Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer","volume":"38","author":"Yang","year":"2021","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0630","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/ol.2021.12868","article-title":"Exosome-derived microRNA-433 inhibits tumorigenesis through incremental infiltration of CD4 and CD8 cells in non-small cell lung cancer","volume":"22","author":"Liu","year":"2021","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb0635","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/10799893.2021.1918166","article-title":"MicroRNA-320a-containing exosomes from human umbilical cord mesenchymal stem cells curtail proliferation and metastasis in lung cancer by binding to SOX4","volume":"42","author":"Xie","year":"2022","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2022.100010","article-title":"Circ_rac GTPase-activating protein 1 facilitates stemness and metastasis of non-small Cell lung cancer via polypyrimidine tract-binding protein 1 recruitment to promote Sirtuin-3-mediated replication timing regulatory factor 1 deacetylation","volume":"103","author":"Xiong","year":"2023","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112834","article-title":"Non-small cell lung cancer cell-derived exosomal miR-17-5p promotes osteoclast differentiation by targeting PTEN","volume":"408","author":"Wang","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cellsig.2026.112452_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.922465","article-title":"Exosomes from cisplatin-induced dormant cancer cells facilitate the formation of premetastatic niche in bone marrow through activating glycolysis of BMSCs","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0655","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.7150\/thno.79250","article-title":"Tumor-derived Cav-1 promotes pre-metastatic niche formation and lung metastasis in breast cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0660","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13058-022-01557-5","article-title":"Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer","volume":"24","author":"Li","year":"2022","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0665","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41467-022-28438-x","article-title":"Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression","volume":"13","author":"Qi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112452_bb0670","first-page":"403","article-title":"Rab1A-mediated exosomal sorting of miR-200c enhances breast cancer lung metastasis","volume":"15","author":"Liu","year":"2023","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.cellsig.2026.112452_bb0675","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.gene.2019.06.004","article-title":"High throughput sequencing identifies breast cancer-secreted exosomal LncRNAs initiating pulmonary pre-metastatic niche formation","volume":"710","author":"Feng","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.cellsig.2026.112452_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101715","article-title":"Exosomal miRNA-223-3p derived from tumor associated macrophages promotes pulmonary metastasis of breast cancer 4T1 cells","volume":"35","author":"Wang","year":"2023","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb0685","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/1078-0432.CCR-22-2682","article-title":"Circulating exosomal PD-L1 at initial diagnosis predicts outcome and survival of patients with osteosarcoma","volume":"29","author":"Wang","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"7718","key":"10.1016\/j.cellsig.2026.112452_bb0690","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0695","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12951-020-00710-6","article-title":"Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients","volume":"18","author":"Wang","year":"2020","journal-title":"J. Nanobiotechnol."},{"issue":"48","key":"10.1016\/j.cellsig.2026.112452_bb0700","doi-asserted-by":"crossref","first-page":"78343","DOI":"10.18632\/oncotarget.13055","article-title":"Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma","volume":"7","author":"Dumars","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb0705","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.7150\/thno.51245","article-title":"H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112452_bb0710","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0715","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12943-019-1049-4","article-title":"Exosomes promote pre-metastatic niche formation in ovarian cancer","volume":"18","author":"Feng","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0720","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41392-020-00414-1","article-title":"Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0725","article-title":"Exosomal-miR-10a derived from colorectal cancer cells suppresses migration of human lung fibroblasts, and expression of IL-6, IL-8 and IL-1\u03b2","volume":"23","author":"Wang","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0730","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-020-01184-8","article-title":"CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17","volume":"19","author":"Han","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112452_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121872","article-title":"Hypoxia derived exosomes promote the proliferation and metastasis of colorectal cancer through the regulation of HIF-1\u03b1\/miR-4299\/ZBTB4","volume":"329","author":"Wu","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.cellsig.2026.112452_bb0740","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221106998","article-title":"Hypoxic tumor-derived exosomes induce M2 macrophage polarization via PKM2\/AMPK to promote lung cancer progression","volume":"31","author":"Zhou","year":"2022","journal-title":"Cell Transplant."},{"issue":"7467","key":"10.1016\/j.cellsig.2026.112452_bb0745","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"issue":"7782","key":"10.1016\/j.cellsig.2026.112452_bb0750","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb0755","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.09.051","article-title":"Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways","volume":"159","author":"Boelens","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb0760","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/1878-0261.12629","article-title":"Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer","volume":"14","author":"Wang","year":"2020","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0765","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mrgentox.2012.03.004","article-title":"Cisplatin treatment leads to changes in nuclear protein and microRNA expression","volume":"746","author":"Zhang","year":"2012","journal-title":"Mutation Research\/Genet. Toxicol. Environ. Mutagenes."},{"key":"10.1016\/j.cellsig.2026.112452_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100937","article-title":"Exosomal circular RNAs: a chief culprit in cancer chemotherapy resistance","volume":"67","author":"Guo","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0775","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13059-018-1604-0","article-title":"Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5","volume":"20","author":"Qin","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.cellsig.2026.112452_bb0780","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drup.2015.11.003","article-title":"Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation","volume":"24","author":"Ferreira","year":"2016","journal-title":"Drug Resist. Updat."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112452_bb0785","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1158\/0008-5472.CAN-16-2524","article-title":"Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of miR-1587","volume":"77","author":"Figueroa","year":"2017","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125625","article-title":"Fibroblast-derived exosomes contribute to chemoresistance through priming cancer stem cells in colorectal cancer","volume":"10","author":"Hu","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0795","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/0929867327666200130103206","article-title":"The emerging roles of exosomes in the chemoresistance of hepatocellular carcinoma","volume":"28","author":"Zhang","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0800","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41598-018-19339-5","article-title":"Exosome-mediated breast cancer chemoresistance via miR-155 transfer","volume":"8","author":"Santos","year":"2018","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.cellsig.2026.112452_bb0805","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.7150\/thno.25541","article-title":"Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19","volume":"8","author":"Ren","year":"2018","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112452_bb0810","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nrclinonc.2015.90","article-title":"Refining the treatment of NSCLC according to histological and molecular subtypes","volume":"12","author":"Thomas","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0815","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1470-2045(13)70604-1","article-title":"Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial","volume":"15","author":"Wu","year":"2014","journal-title":"Lancet Oncol."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112452_bb0820","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"First-line crizotinib versus chemotherapy in ALK-positive lung cancer","volume":"371","author":"Solomon","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0825","first-page":"191","article-title":"Drug resistance to EGFR tyrosine kinase inhibitors for non-small cell lung cancer","volume":"68","author":"Shien","year":"2014","journal-title":"Acta Med. Okayama"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112452_bb0830","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1158\/1078-0432.CCR-06-3043","article-title":"KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer","volume":"13","author":"Massarelli","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"31","key":"10.1016\/j.cellsig.2026.112452_bb0835","doi-asserted-by":"crossref","first-page":"E2127","DOI":"10.1073\/pnas.1203530109","article-title":"Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1","volume":"109","author":"Ohashi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0840","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nm.2713","article-title":"A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer","volume":"18","author":"Ng","year":"2012","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0845","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/1535-7163.MCT-12-0620","article-title":"EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics","volume":"12","author":"Arcila","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"7408","key":"10.1016\/j.cellsig.2026.112452_bb0850","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature11249","article-title":"Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors","volume":"487","author":"Wilson","year":"2012","journal-title":"Nature"},{"issue":"7339","key":"10.1016\/j.cellsig.2026.112452_bb0855","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature09870","article-title":"FAS and NF-\u03baB signalling modulate dependence of lung cancers on mutant EGFR","volume":"471","author":"Bivona","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0860","first-page":"10","article-title":"T790M and acquired resistance of EGFR TKI: a literature review of clinical reports","volume":"3","author":"Ma","year":"2011","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0865","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.apsb.2015.07.001","article-title":"Mechanisms of resistance to EGFR tyrosine kinase inhibitors","volume":"5","author":"Huang","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb0870","first-page":"230","article-title":"Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer","volume":"1","author":"Van Der Steen","year":"2018","journal-title":"Cancer Drug Resist."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112452_bb0875","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa1007478","article-title":"EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors","volume":"363","author":"Choi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"120","key":"10.1016\/j.cellsig.2026.112452_bb0880","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003728","article-title":"Escaping ALK inhibition: mechanisms of and strategies to overcome resistance","volume":"4","author":"Lovly","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112452_bb0885","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-16-0596","article-title":"Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer","volume":"6","author":"Gainor","year":"2016","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0890","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1158\/1078-0432.CCR-19-1104","article-title":"Diverse resistance mechanisms to the third-generation ALK inhibitor Lorlatinib in ALK-rearranged lung cancer","volume":"26","author":"Recondo","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb0895","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.trecan.2016.05.010","article-title":"Resisting resistance: targeted therapies in lung cancer","volume":"2","author":"Lin","year":"2016","journal-title":"Trends Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112452_bb0900","first-page":"3438","article-title":"Tumor-released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non-small cell lung cancer","volume":"40","author":"Lei","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellsig.2026.112452_bb0905","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.2147\/CMAR.S241095","article-title":"Exosomal transfer of lncRNA H19 promotes erlotinib resistance in non-small cell lung cancer via miR-615-3p\/ATG7 axis","volume":"12","author":"Pan","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112452_bb0910","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00595-020-01976-x","article-title":"Cancer exosomal microRNAs from gefitinib-resistant lung cancer cells cause therapeutic resistance in gefitinib-sensitive cells","volume":"50","author":"Azuma","year":"2020","journal-title":"Surg. Today"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112452_bb0915","first-page":"9811","article-title":"Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21","volume":"15","author":"Jing","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0920","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/jcmm.14838","article-title":"Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K\/AKT signalling pathway","volume":"24","author":"Liu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"1\u20134","key":"10.1016\/j.cellsig.2026.112452_bb0925","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bbrc.2018.11.061","article-title":"Exosomal transfer of miR-214 mediates gefitinib resistance in non-small cell lung cancer","volume":"507","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112452_bb0930","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/1759-7714.13943","article-title":"Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cells","volume":"12","author":"Hisakane","year":"2021","journal-title":"Thorac. Cancer"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112452_bb0935","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.18632\/aging.203011","article-title":"Tumor-derived exosomal circRNA_102481 contributes to EGFR-TKIs resistance via the miR-30a-5p\/ROR1 axis in non-small cell lung cancer","volume":"13","author":"Yang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0940","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12943-021-01307-9","article-title":"Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer","volume":"20","author":"Wu","year":"2021","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0945","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s13577-021-00572-6","article-title":"Exosomal long non-coding RNA SOX2 overlapping transcript enhances the resistance to EGFR-TKIs in non-small cell lung cancer cell line H1975","volume":"34","author":"Zhou","year":"2021","journal-title":"Hum. Cell"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb0950","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1021\/acs.molpharmaceut.7b00277","article-title":"Overexpression of ATP-binding cassette subfamily G member 2 confers resistance to Phosphatidylinositol 3-Kinase inhibitor PF-4989216 in cancer cells","volume":"14","author":"Wu","year":"2017","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102177","article-title":"Enigmatic exosomal connection in lung cancer drug resistance","volume":"35","author":"Patra","year":"2024","journal-title":"Mol. Ther. Nucleic Acids."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0960","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1186\/s12885-018-4990-5","article-title":"Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance","volume":"18","author":"Pu","year":"2018","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb0965","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2018.03.007","article-title":"Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies","volume":"48","author":"Patel","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0970","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/PPO.0000000000000303","article-title":"Mechanisms of resistance to PD-1 and PD-L1 blockade","volume":"24","author":"Nowicki","year":"2018","journal-title":"Cancer J."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112452_bb0975","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1158\/2159-8290.CD-17-0593","article-title":"Impaired HLA Class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer","volume":"7","author":"Gettinger","year":"2017","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0980","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1249561","article-title":"Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer","volume":"6","author":"Huang","year":"2017","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb0985","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb0990","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.imbio.2008.10.007","article-title":"Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells","volume":"214","author":"Wang","year":"2009","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112452_bb0995","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.coi.2008.09.006","article-title":"CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas","volume":"20","author":"Piccirillo","year":"2008","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb1000","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","article-title":"Unleashing Type-2 dendritic cells to drive protective antitumor CD4(+) T cell immunity","volume":"177","author":"Binnewies","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb1005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00262-013-1508-5","article-title":"Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab","volume":"63","author":"Meyer","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb1010","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb1015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020287","article-title":"Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers","volume":"12","author":"Do","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The therapeutic potential of targeting tryptophan catabolism in cancer","volume":"122","author":"Opitz","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb1025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/15384047.2014.1002353","article-title":"PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism","volume":"16","author":"Li","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb1030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1158\/1078-0432.CCR-17-1841","article-title":"Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer","volume":"24","author":"Arbour","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112452_bb1035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238358","article-title":"STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world","volume":"15","author":"Shire","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-019-0975-5","article-title":"Exosomes in the tumor microenvironment as mediators of cancer therapy resistance","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112452_bb1045","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41422-018-0060-4","article-title":"Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101047","article-title":"The role of exosomal PD-L1 in tumor immunotherapy","volume":"14","author":"Wang","year":"2021","journal-title":"Transl. Oncol."},{"issue":"7077","key":"10.1016\/j.cellsig.2026.112452_bb1055","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb1060","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ijc.30669","article-title":"The role of exosomes and miRNAs in drug-resistance of cancer cells","volume":"141","author":"Bach","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cellsig.2026.112452_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111111","article-title":"Progress of exosomes in the diagnosis and treatment of lung cancer","volume":"134","author":"Xu","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12967-022-03392-w","article-title":"Mechanism and clinical value of exosomes and exosomal contents in regulating solid tumor radiosensitivity","volume":"20","author":"Sun","year":"2022","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-019-0970-x","article-title":"Therapy resistance mediated by exosomes","volume":"18","author":"Steinbichler","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112452_bb1080","first-page":"43","article-title":"The role and clinical applications of exosomes in cancer drug resistance","volume":"7","author":"Pan","year":"2024","journal-title":"Cancer Drug Resist."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/medsci12010004","article-title":"Extracellular vesicles\u2019 role in angiogenesis and altering angiogenic signaling","volume":"12","author":"Ateeq","year":"2024","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12967-020-02426-5","article-title":"Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications","volume":"18","author":"Ahmadi","year":"2020","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.21037\/tcr.2019.01.03","article-title":"Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application","volume":"8","author":"Liu","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112452_bb1100","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1379822","article-title":"Exosomes: a significant medium for regulating drug resistance through cargo delivery","volume":"11","author":"Ren","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cellsig.2026.112452_bb1105","doi-asserted-by":"crossref","first-page":"S1040","DOI":"10.21037\/tcr.2017.07.09","article-title":"Exosome mediated phenotypic changes in lung cancer pathophysiology","author":"Shimada","year":"2017","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1110","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12935-024-03544-6","article-title":"Exosome therapeutics for non-small cell lung cancer tumorigenesis","volume":"24","author":"Orooji","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-021-01312-y","article-title":"Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112452_bb1120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1471476","article-title":"Role of exosomes in modulating non-small cell lung cancer radiosensitivity","volume":"15","author":"Fang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112452_bb1125","doi-asserted-by":"crossref","first-page":"13669","DOI":"10.3390\/ijms241813669","article-title":"The comparison of serum exosome protein profile in diagnosis of NSCLC patients","volume":"24","author":"Baran","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1130","doi-asserted-by":"crossref","first-page":"26659","DOI":"10.3402\/jev.v4.26659","article-title":"Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma","volume":"4","author":"Jakobsen","year":"2015","journal-title":"J. Extracell. Vesicles"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112452_bb1135","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.molonc.2016.10.003","article-title":"Exosomal proteins as prognostic biomarkers in non-small cell lung cancer","volume":"10","author":"Sandfeld-Paulsen","year":"2016","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb1140","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/cancers14030732","article-title":"Exosomal proteins and lipids as potential biomarkers for lung cancer diagnosis, prognosis, and treatment","volume":"14","author":"Hsu","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb1145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101170","article-title":"Exosomes in ovarian cancer: impact on drug resistance and advances in SERS detection techniques","volume":"15","author":"Chen","year":"2025","journal-title":"J. Pharm. Analys."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-019-1095-1","article-title":"Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype","volume":"38","author":"Zhu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112452_bb1155","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.21873\/anticanres.16092","article-title":"Evaluation of the diagnostic potential of circulating MicroRNAs <em>miR-1<\/em> and <em>miR-21<\/em> in patients with ovarian cancer","volume":"42","author":"Ralser","year":"2022","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112452_bb1160","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/ijms21062118","article-title":"Exosomes in prostate cancer diagnosis, prognosis and therapy","volume":"21","author":"Lorenc","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112452_bb1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112832","article-title":"Tumor-derived exosomes: the emerging orchestrators in melanoma","volume":"149","author":"Tan","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112452_bb1170","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2026.112452_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217425","article-title":"Corrigendum to \u201cCellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma\u201d [Cancer Lett. 604 (2024) 217272]","volume":"611","author":"Huang","year":"2025","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112452_bb1180","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/1535-7163.MCT-17-0148","article-title":"JAK1\/STAT3 activation through a proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non\u2013small cell lung cancer","volume":"16","author":"Shien","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"10066","key":"10.1016\/j.cellsig.2026.112452_bb1185","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"issue":"44","key":"10.1016\/j.cellsig.2026.112452_bb1190","doi-asserted-by":"crossref","first-page":"76116","DOI":"10.18632\/oncotarget.18814","article-title":"Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6\/STAT3 signaling pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb1195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/or.2024.8714","article-title":"Advances of HIF-1\u03b1\/glycolysis axis in non-small cell lung cancer (Review)","volume":"51","author":"Shi","year":"2024","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2026.112452_bb1205","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27522","article-title":"Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis","volume":"4","author":"An","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.cellsig.2026.112452_bb1210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114487","article-title":"Exosomes: powerful weapon for cancer nano-immunoengineering","volume":"186","author":"Pi","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112452_bb1215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.semcdb.2017.07.035","article-title":"Non-coding RNAs as a new dawn in tumor diagnosis","volume":"78","author":"Grimaldi","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.cellsig.2026.112452_bb1220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.gene.2017.04.031","article-title":"Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer","volume":"623","author":"Yang","year":"2017","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112452_bb1225","article-title":"Biogenesis, isolation, and detection of exosomes and their potential in therapeutics and diagnostics","volume":"13","author":"Sonbhadra","year":"2023","journal-title":"Biosensors (Basel)."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112452_bb1230","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060888","article-title":"Exo-miRNAs as a new tool for liquid biopsy in lung cancer","volume":"11","author":"Fortunato","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1235","first-page":"1099","article-title":"LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204","volume":"6","author":"Li","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1240","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ccell.2022.04.002","article-title":"The translational challenges of precision oncology","volume":"40","author":"Pich","year":"2022","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb1245","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cellsig.2026.112452_bb1250","article-title":"Tumor-derived exosomal miRNAs as diagnostic biomarkers in non-small cell lung cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112452_bb1255","first-page":"1","article-title":"Tissue and blood biomarkers in lung cancer: a review","volume":"86","author":"Duffy","year":"2018","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.cellsig.2026.112452_bb1260","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6691211","article-title":"Tumor-derived exosomal miR-620 as a diagnostic biomarker in non-small-cell lung cancer","volume":"2020","author":"Tang","year":"2020","journal-title":"J. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1265","first-page":"5197","article-title":"Exosomal long non-coding RNA DLX6-AS1 as a potential diagnostic biomarker for non-small cell lung cancer","volume":"18","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb1270","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7150\/ijbs.39123","article-title":"Exploration of serum exosomal LncRNA TBILA and AGAP2-AS1 as promising biomarkers for diagnosis of non-small cell lung cancer","volume":"16","author":"Tao","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1275","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1186\/s12885-023-11567-x","article-title":"Lymphocyte migration regulation related proteins in urine exosomes may serve as a potential biomarker for lung cancer diagnosis","volume":"23","author":"Jin","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12575-023-00223-0","article-title":"Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer","volume":"25","author":"Luo","year":"2023","journal-title":"Biol. Proced. Online"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1285","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.7150\/jca.52320","article-title":"Plasma exosome-derived B-cell translation gene 1: a predictive marker for the prognosis in patients with non-small cell lung cancer","volume":"12","author":"Wan","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.cellsig.2026.112452_bb1290","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.2147\/OTT.S263934","article-title":"Serum exosomal miR-1290 is a potential biomarker for lung adenocarcinoma","volume":"13","author":"Wu","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1295","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/cas.13581","article-title":"Circulating exosomes contain protein biomarkers of metastatic non-small-cell lung cancer","volume":"109","author":"Wang","year":"2018","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1300","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/CBM-190914","article-title":"Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer","volume":"27","author":"Liu","year":"2020","journal-title":"Cancer Biomark."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1305","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12931-023-02423-4","article-title":"Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer","volume":"24","author":"Chang","year":"2023","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1310","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40364-023-00517-1","article-title":"Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer","volume":"11","author":"Kim","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cellsig.2026.112452_bb1315","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbior.2014.10.002","article-title":"Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes","volume":"57","author":"Shamseddine","year":"2015","journal-title":"Adv. Biol. Regul."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1320","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ncb2000","article-title":"Rab27a and Rab27b control different steps of the exosome secretion pathway","volume":"12","author":"Ostrowski","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1325","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.celrep.2013.10.050","article-title":"Exosome secretion is enhanced by invadopodia and drives invasive behavior","volume":"5","author":"Hoshino","year":"2013","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112452_bb1330","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/cas.13310","article-title":"Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells","volume":"108","author":"Matsumoto","year":"2017","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1335","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1038\/s41467-021-25990-w","article-title":"A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"28","key":"10.1016\/j.cellsig.2026.112452_bb1340","doi-asserted-by":"crossref","first-page":"E5549","DOI":"10.1073\/pnas.1705134114","article-title":"Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation","volume":"114","author":"Airola","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb1345","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/jcm9020436","article-title":"Inclusion biogenesis, methods of isolation and clinical application of human cellular exosomes","volume":"9","author":"Tschuschke","year":"2020","journal-title":"J. Clin. Med."},{"issue":"40","key":"10.1016\/j.cellsig.2026.112452_bb1350","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5210","article-title":"Inhibition of neutral sphingomyelinase 2 promotes remyelination","volume":"6","author":"Yoo","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cellsig.2026.112452_bb1355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2017.08.020","article-title":"Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras\/Raf\/ERK1\/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells","volume":"408","author":"Datta","year":"2017","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1360","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1038\/s41598-018-26411-7","article-title":"High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: a drug repurposing strategy for advanced cancer","volume":"8","author":"Datta","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1365","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1038\/s41598-021-89655-w","article-title":"Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma","volume":"11","author":"Greenberg","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb1370","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/cas.15225","article-title":"Epidermal growth factor\/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis","volume":"113","author":"Sasabe","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellsig.2026.112452_bb1375","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijbiomac.2021.07.110","article-title":"Heparan sulfate analogues regulate tumor-derived exosome formation that attenuates exosome functions in tumor processes","volume":"187","author":"Wu","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1380","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41467-019-09387-4","article-title":"Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A","volume":"10","author":"Im","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1385","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103245","article-title":"Sulfisoxazole elicits robust antitumour immune response along with immune checkpoint therapy by inhibiting exosomal PD-L1","volume":"9","author":"Shin","year":"2022","journal-title":"Adv. Sci."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112452_bb1390","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nsmb.3136","article-title":"Structural characterization of human heparanase reveals insights into substrate recognition","volume":"22","author":"Wu","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112452_bb1395","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1200\/JCO.2005.03.134","article-title":"The effect of low molecular weight heparin on survival in patients with advanced malignancy","volume":"23","author":"Klerk","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112452_bb1400","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00432-016-2131-6","article-title":"Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms","volume":"142","author":"Zhang","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb1405","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/jth.12595","article-title":"The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials","volume":"12","author":"Sanford","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1410","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3727\/000000006783981053","article-title":"In vitro study of low molecular weight heparin effect on cell growth and cell invasion in primary cell cultures of high-grade gliomas","volume":"16","author":"Balzarotti","year":"2006","journal-title":"Oncol. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb1415","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/07853890.2015.1004361","article-title":"Low-molecular-weight heparins and cancer: focus on antitumoral effect","volume":"47","author":"Franchini","year":"2015","journal-title":"Ann. Med."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112452_bb1420","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1139\/y11-068","article-title":"Concentration- and time-dependent effects of enoxaparin on human adenocarcinomic epithelial cell line A549 proliferation in vitro","volume":"89","author":"Abu Arab","year":"2011","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"18_suppl","key":"10.1016\/j.cellsig.2026.112452_bb1425","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2006.24.18_suppl.13093","article-title":"The mechanism of low molecular weight heparin (LMWH) inhibition of tumor growth","volume":"24","author":"Smiley","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"19 Pt 1","key":"10.1016\/j.cellsig.2026.112452_bb1430","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-05-1131","article-title":"Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity","volume":"11","author":"Stevenson","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1435","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1158\/1078-0432.CCR-06-1987","article-title":"Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids?","volume":"13","author":"Harvey","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1440","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.thromres.2007.06.015","article-title":"Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin","volume":"121","author":"Marchetti","year":"2008","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb1445","first-page":"258","article-title":"Anti-cancer properties of low-molecular-weight heparin: preclinical evidence","volume":"102","author":"Mousa","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb1450","first-page":"627","article-title":"Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor","volume":"92","author":"Mousa","year":"2004","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1455","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2014.02.010","article-title":"The potential of heparanase as a therapeutic target in cancer","volume":"89","author":"Pisano","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112452_bb1460","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-3-642-23056-1_16","article-title":"Heparin mimetics","volume":"207","author":"Coombe","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"issue":"240","key":"10.1016\/j.cellsig.2026.112452_bb1465","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008362","article-title":"RNAi therapies: drugging the undruggable","volume":"6","author":"Wu","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb1470","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1475","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ydbio.2008.02.035","article-title":"Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation","volume":"317","author":"Gontan","year":"2008","journal-title":"Dev. Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112452_bb1480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011022","article-title":"Evidence that SOX2 overexpression is oncogenic in the lung","volume":"5","author":"Lu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2026.112452_bb1485","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106200","article-title":"tLyp-1: a peptide suitable to target NRP-1 receptor","volume":"130","author":"Larue","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb1490","first-page":"461","article-title":"Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells","volume":"15","author":"Bai","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1495","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS mutation: from undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1500","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-022-01629-2","article-title":"Targeting KRAS mutant cancers: from druggable therapy to drug resistance","volume":"21","author":"Zhu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41544-019-0034-9","article-title":"Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth","volume":"1","author":"Zhou","year":"2019","journal-title":"ExRNA"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1510","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0598-594","article-title":"Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes","volume":"4","author":"Zitvogel","year":"1998","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112452_bb1515","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1084\/jem.173.5.1099","article-title":"Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes","volume":"173","author":"Peters","year":"1991","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112452_bb1520","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/eji.1830190819","article-title":"Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes","volume":"19","author":"Peters","year":"1989","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb1525","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.4049\/jimmunol.168.7.3235","article-title":"TCR activation of human T cells induces the production of exosomes bearing the TCR\/CD3\/zeta complex","volume":"168","author":"Blanchard","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2026.112452_bb1530","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5879616","article-title":"Circulating cancer stem cell-derived extracellular vesicles as a novel biomarker for clinical outcome evaluation","volume":"2019","author":"Brocco","year":"2019","journal-title":"J. Oncol."},{"issue":"42","key":"10.1016\/j.cellsig.2026.112452_bb1535","doi-asserted-by":"crossref","first-page":"44179","DOI":"10.18632\/oncotarget.6175","article-title":"Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.cellsig.2026.112452_bb1540","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194748","article-title":"High blood concentration of leukocyte-derived extracellular vesicles is predictive of favorable clinical outcomes in patients with pancreatic cancer: results from a multicenter prospective study","volume":"14","author":"Brocco","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1545","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/s41467-019-12321-3","article-title":"CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity","volume":"10","author":"Fu","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112452_bb1550","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41591-018-0201-9","article-title":"Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell","volume":"24","author":"Ruella","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1555","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-3-9","article-title":"A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer","volume":"3","author":"Morse","year":"2005","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1560","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-022-01586-w","article-title":"The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p\/CARM1 axis","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb1565","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1071008","article-title":"Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC","volume":"5","author":"Besse","year":"2016","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112452_bb1570","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1021\/acs.molpharmaceut.8b00277","article-title":"Exosomes as a drug delivery system in cancer therapy: potential and challenges","volume":"15","author":"Kibria","year":"2018","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112452_bb1575","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1615\/CritRevImmunol.v29.i3.20","article-title":"Exosome release by primary B cells","volume":"29","author":"McLellan","year":"2009","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2026.112452_bb1580","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/sci-2022-030","article-title":"Exosome-based cancer vaccine for prevention of lung cancer","volume":"10","author":"Meng","year":"2023","journal-title":"Stem Cell Investig."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yexmp.2016.05.013","article-title":"Exosomal formulation enhances therapeutic response of celastrol against lung cancer","volume":"101","author":"Aqil","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.cellsig.2026.112452_bb1590","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.2147\/IJN.S131516","article-title":"Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner","volume":"12","author":"Qin","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1595","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s12935-021-02157-7","article-title":"Engineered exosomes loaded with miR-449a selectively inhibit the growth of homologous non-small cell lung cancer","volume":"21","author":"Zhou","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cellsig.2026.112452_bb1600","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6141857","article-title":"Engineered exosomes loaded with miR-563 inhibit lung cancer growth","volume":"2022","author":"Gao","year":"2022","journal-title":"J. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112452_bb1605","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1039\/C9NR09011H","article-title":"Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer","volume":"12","author":"Nie","year":"2020","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1610","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12967-023-04206-3","article-title":"Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer","volume":"21","author":"Zheng","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112452_bb1615","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100915","article-title":"Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy","volume":"67","author":"Yu","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1620","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12935-023-02974-y","article-title":"Exosome-derived circKIF20B suppresses gefitinib resistance and cell proliferation in non-small cell lung cancer","volume":"23","author":"Wei","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1625","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-024-02099-4","article-title":"LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer","volume":"23","author":"Wu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"22","key":"10.1016\/j.cellsig.2026.112452_bb1630","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1111\/jcmm.17933","article-title":"Inhibitory role of bone marrow mesenchymal stem cells-derived exosome in non-small-cell lung cancer: microRNA-30b-5p, EZH2 and PI3K\/AKT pathway","volume":"27","author":"Wu","year":"2023","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb1635","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1080\/21655979.2022.2036891","article-title":"MicroRNA-631 deriving from bone marrow mesenchymal stem cell exosomes facilitates the malignant behavior of non-small cell lung cancer via modulating the E2F family of transcription factor 2\/phosphatidylinositol 3-kinase\/Akt signaling pathway","volume":"13","author":"Lv","year":"2022","journal-title":"Bioengineered"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112452_bb1640","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4149\/neo_2021_201208N1328","article-title":"microRNA-204 shuttled by mesenchymal stem cell-derived exosomes inhibits the migration and invasion of non-small-cell lung cancer cells via the KLF7\/AKT\/HIF-1\u03b1 axis","volume":"68","author":"Liu","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.cellsig.2026.112452_bb1645","doi-asserted-by":"crossref","first-page":"38541","DOI":"10.1038\/srep38541","article-title":"Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells","volume":"6","author":"Srivastava","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2026.112452_bb1650","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2017.02.004","article-title":"Exosomal formulation of anthocyanidins against multiple cancer types","volume":"393","author":"Munagala","year":"2017","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1655","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nano.2017.09.011","article-title":"Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations","volume":"14","author":"Kim","year":"2018","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1660","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1080\/10717544.2021.1951894","article-title":"Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation in vitro and in vivo","volume":"28","author":"Wang","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.cellsig.2026.112452_bb1665","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112290","article-title":"An integrative microfluidic device for isolation and ultrasensitive detection of lung cancer-specific exosomes from patient urine","volume":"163","author":"Yang","year":"2020","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.cellsig.2026.112452_bb1670","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216093","article-title":"Tumor-targeted exosomes for delivery of anticancer drugs","volume":"558","author":"Raguraman","year":"2023","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112452_bb1675","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41580-023-00576-0","article-title":"Context-specific regulation of extracellular vesicle biogenesis and cargo selection","volume":"24","author":"Dixson","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112452_bb1680","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41565-024-01774-3","article-title":"Harnessing extracellular vesicle heterogeneity for diagnostic and therapeutic applications","volume":"20","author":"Carney","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112452_bb1685","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060824","article-title":"Dual-omics approach unveils novel perspective on the quality control of genetically engineered exosomes","volume":"16","author":"Olson","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cellsig.2026.112452_bb1690","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-025-00922-4","article-title":"Biology and therapeutic potential of extracellular vesicle targeting and uptake","author":"Ripoll","year":"2026","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112452_bb1695","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/s41587-024-02426-6","article-title":"Amplifying mutational profiling of extracellular vesicle mRNA with SCOPE","volume":"43","author":"Song","year":"2025","journal-title":"Nat. Biotechnol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826001026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826001026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:34:22Z","timestamp":1785292462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826001026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":339,"alternative-id":["S0898656826001026"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112452","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosome-mediated crosstalk between immune cells and tumor microenvironment in lung cancer: Implications for immune evasion and therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112452"}}